FDA Clearance Tracker · P220025-S002
LimFlow System, LimFlow Crossing Stent Graft, LimFlow Extension Stent Graft
Last checked: Nov 20, 2026Latest source record: Jul 11, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Jul 11, 2024
Approved
Time to decision
115 days
Received Mar 18, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P220025-S002
- Device name
- LimFlow System, LimFlow Crossing Stent Graft, LimFlow Extension Stent Graft
- Applicant
- LimFlow, Inc.
- Applicant location
- San Jose, CA
- Received
- Mar 18, 2024
- Decided
- Jul 11, 2024
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P220025
Device type
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
Approval for the thumbwheel delivery system and contract manufacturer, Confluent Medical (Alajuela, Costa Rica), and new contract sterilizer, Steris AST (Alajuela, Costa Rica)
Source documents
Other decisions for LimFlow, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- LimFlow Vector510(k)
K260188 · Decided Mar 18, 2026 · 55 days after receipt
Device type: Valvulotome (MGZ) · Cardiology
6 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.